Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4
Clinical trial NCT06548815 · COMPLETED
Trial details
- NCT number
- NCT06548815
- Sponsor
- Gan and Lee Pharmaceuticals, USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-29
- Primary completion
- 2023-03-24
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.